Children with localized scleroderma responded better to methotrexate than to prednisone in a small, placebo-controlled trial, Dr. Francesco Zulian reports.
> more Connective Tissue Diseases articles
| Jun 6 - 9 Berlin, | EULAR (European League Against Rheumatism): 2012 Congress |
| Aug 23 - 25 San Francisco, CA | University of California, San Francisco (UCSF): Rheumatology Board Review and Clinical Update |
| Sep 2 - 5 Copenhagen, | Scandinavian Congress of Rheumatology (SCR) |
| Sep 28 - 29 Newport Beach, CA | 5th Annual Perspectives in Rheumatic Diseases presented by Rheumatology News, Internal Medicine News & Family Practice News |
| Nov 9 - 14 Washington, DC | American College of Rheumatology (ACR): Annual Scientific Meeting |
| Nov 14 - 17 Prague, | Connective Tissue Oncology Society (CTOS): Annual Meeting |
| Jan 26 - Feb 1 , | American College of Rheumatology (ACR): Winter Rheumatology Symposium |
| Feb 6 - 9 Maui, HI | Rheumatology Winter Clinical Symposium 2013 |
| Feb 13 - 16 Ottawa, | Canadian Rheumatology Association (CRA): Scientific Conference and Annual General Meeting |
| Sep 21 - 25 Natal, | 11th World Congress on Inflammation |